• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Congestive Heart Failure – Major World Markets, Volume II – Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)

$995.00 – $1,990.00

Clear
SKU: KLI1638430 Category: Medical Devices Market Research Pages: 250
  • Description
  • Table of Contents
  • Latest reports

Description

Congestive heart failure, a condition caused by a malfunctioning heart that is unable to pump enough blood and oxygen to meet the body’s needs, is an increasingly important cause of cardiovascular morbidity and mortality. With improvements in the care of other cardiac conditions, more patients have developed dilated cardiomyopathy, which is the final common pathway for many cardiac illnesses and a common cause of congestive heart failure.

Kalorama Information’s Congestive Heart Failure, Major World Markets series looks at markets for CHF treatment in the United States, Europe, Japan and the Rest of the World. Volume II of this series looks at markets for device management of this disease in the following key categories:

  • Pacemakers
  • Left Ventricular Assistance Devices (LVADs)
  • Implantable Cardioverter/Defibrillators (ICDs)
  • Artificial Hearts

The report offers revenue breakdowns the following world markets:

  • US
  • Europe
  • Japan
  • Rest of World

In addition to market forecasts and current market information, this report contains a thorough review of products available on the market and profiles of key companies, including:

  • Abbott Laboratories
  • Abiomed, Inc.
  • Ambu, USA
  • Aortech International, plc
  • Arrow International
  • Atrium Medical Corporation
  • ATS Medical, Inc.
  • Bacchus Vascular, Inc.
  • Berlin Heart AG
  • Biophan Technologies, Inc.
  • Biosensors International
  • Biotronik, Inc.
  • Boston Scientific
  • CardiacAssist, Inc.
  • Cardiac Science Corporation
  • Cardiogenesis Corporation
  • Cordis Corporation/Biologics Delivery Systems
  • CoreValve, Inc.
  • CryoCath Technologies, Inc.
  • Cryocor, Inc.
  • Datascope
  • Defibtech, LLC
  • Deltex Medical
  • Heartlab
  • Impulse Dynamics USA, Inc.
  • MedicalCV, Inc.
  • Medtronic, Inc.
  • Orqis Medical Corporation
  • Sorin SpA
  • Stereotaxis, Inc.
  • St. Jude Medical, Inc.
  • Teleflex Medical
  • Terumo Heart, Inc.
  • Thoratec Corporation
  • Ventracor, Inc.
  • Volcano Corporation

As part of Kalorama Information’s methodology, analyst estimates are computed with intensive research of secondary data and literature, and primary research involving interviews of experts are used to test assumptions and validate models.

Product managers, business development executives, marketing executives and planners are among those who will benefit from this resource.


License Note: Kalorama Information’s listed default price on its information products reflects a single user license only. Purchasing a departmental license (up to 10 users at one location) or a global site license (entire company) permits multiple individuals in the company to benefit from this resource.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Scope and Methodology
  • Size and Growth of Market

CHAPTER  TWO: OVERVIEW OF CHF

  • Background
  • Pathophysiology
    • Types of Heart Failure
    • Left Ventricular (LV) Failure
    • Right Ventricular (RV) Failure
    • Systolic Dysfunction
    • Diastolic Dysfunction
    • High Output Failure
    • Theories of Congestive Heart Failure
    • Hemodynamic Response Theory
    • Neurohormonal Response Theory
    • Renal Response Theory
    • Conditions Leading to Congestive Heart Failure
    • Myocardial Infarction
    • Hypertension
    • Cardiomyopathy
    • Atrial Fibrillation
    • Other Risk Factor
    • Diagnosis of Congestive Heart Failure
    • Classification of Congestive Heart Failure Patients
    • Epidemiology
    • United States
    • Europe
    • Japan

CHAPTER THREE: DEVICE TREATMENT OF CONGESTIVE HEART FAILURE

  • Artificial Pacemaker
  • Ventricular Assist Devices (VADs)
  • Total Artificial Hearts (TAHs)
  • American College of Cardiology Guideline

CHAPTER FOUR: CONGESTIVE HEART FAILURE PATIENT MANAGEMENT

  • Guidelines for Management of Chronic Heart Failure
  • Strategies to Maintain Quality Patient Care and Contain Costs

CHAPTER FIVE: WORLD MARKETS

  • United States
  • Europe
  • Japan

CHAPTER  SIX: COMPANY PROFILES

  • Abbott Laboratories
  • Abiomed, Inc.
  • Ambu, USA
  • Aortech International, plc
  • Arrow International
  • Atrium Medical Corporation
  • ATS Medical, Inc.
  • Bacchus Vascular, Inc.
  • Berlin Heart AG
  • Biophan Technologies, Inc.
  • Biosensors International
  • Biotronik, Inc.
  • Boston Scientific
  • CardiacAssist, Inc.
  • Cardiac Science Corporation
  • Cardiogenesis Corporation
  • Cordis Corporation/Biologics Delivery Systems
  • CoreValve, Inc.
  • CryoCath Technologies, Inc.
  • Cryocor, Inc.
  • Datascope
  • Defibtech, LLC
  • Deltex Medical
  • Heartlab
  • Impulse Dynamics USA, Inc.
  • MedicalCV, Inc.
  • Medtronic, Inc.
  • Orqis Medical Corporation
  • Sorin SpA
  • Stereotaxis, Inc.
  • St. Jude Medical, Inc.
  • Teleflex Medical
  • Terumo Heart, Inc.
  • Thoratec Corporation
  • Ventracor, Inc.
  • Volcano Corporation

CHAPTER SEVEN: STRATEGIC CONCLUSIONS

  • First Conclusion
  • Second Conclusion
  • Implications:
  • Third Conclusion
  • Implications:
  • Fourth Conclusion
  • Implications:
  • Fifth Conclusion
  • Implications:
  • Sixth Conclusion
  • Implications:
  • Seventh Conclusion
  • Implications:
  • Eighth Conclusion
  • Implications:

APPENDIX A

TABLE OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: Incidence of Congestive Heart Failure Cases in the Major World
  • Healthcare Markets: 2007 – 2017
  • Figure 1-2: Prevalence of Congestive Heart Failure Cases in the Major World
  • Healthcare Markets: 2007 – 2017
  • Table 1-1: The Estimated Markets for Devices Used to Treat CHF in the Major
  • World Healthcare Markets by Geographic Segment
  • Figure 1-3 Trending in the Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment
  • Figure 1-4: Distribution of the Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment

CHAPTER  TWO: OVERVIEW OF CHF

  • Table 2-1: International Cardiovascular Disease (CVD) Statistics  
  • Table 2-2: United States CHF Statistics: 2004
  • Table 2-3: CHF Data Sources
  • Table 2-4: Common Contributors to Congestive Heart Failure
  • Figure 2-1: Incidence and Prevalence of Congestive Heart Failure In the World’s Major Healthcare Markets: 2007 – 2017  
  • Figure 2-2: Incidence Rates of Congestive Heart Failure in the Major World
  • Healthcare Markets: 200l – 2017 (Cases per Million Population)
  • Figure 2-3: Prevalence Rates of Congestive Heart Failure in the Major World
  • Healthcare Markets: 2007 – 2017 (Cases per Million Population)
  • Figure 2-4: Percentage Breakdown of Deaths from Cardiovascular Diseases: 2003  
  • Table 2-5: Incidence and Prevalence of CHF in the United States:   2007 – 2017
  • Figure 2-5: Incidence and Prevalence of CHF in the United States:   2007 – 20017
  • Figure 2-6: The Distribution of Congestive Heart Failure In the Five Major European Healthcare Markets:  2007
  • Table 2-6: Incidence and Prevalence of CHF in the Major Healthcare Markets of Europe:  2007 – 2017 (Thousands)
  • Figure 2-7: Incidence and Prevalence of CHF in the Major Healthcare Markets of Europe:  2007 – 20017 (Thousands)  
  • Table 2-7: Incidence and Prevalence of CHF in Japan:  2007 – 2017
  • Figure 2-8: Incidence and Prevalence of CHF in Japan:  2007 – 20017

CHAPTER THREE: DEVICE TREATMENT OF CONGESTIVE HEART FAILURE

  • Table 3-1: Key Implantable Heart Pacing Devices
  • Table 3-2: Vascular Assist Devices
  • Table 3-3: Total Artificial Heart Devices
  • Table 3-4: Facilities Authorized to Performs Total Artificial Heart Implants

CHAPTER FOUR: CONGESTIVE HEART FAILURE PATIENT MANAGEMENT

  • Figure 4-1: ACC/AHA Guideline Summary for Recommended Therapy of Congestive Heart Failure by Stage of the Disease
  • Table 4-1: ACC/AHA Staging of Congestive Heart Failure
  • Table 4-2: 2005 ACC/AHA Guidelines for Evaluation and Therapy for Congestive Heart Failure:

CHAPTER FOUR: CONGESTIVE HEART FAILURE MARKETS

  • Table 5-1: The Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment  
  • Figure 5-1: Trending in the Estimated Markets for Devices Used to Treat CHF in the Major World Healthcare Markets by Geographic Segment
  • Figure 5-2: Distribution of the Estimated Markets for Devices Used  to Treat CHF in the Major World Healthcare Markets  by Geographic Segment
  • Table 5-2: The Estimated Markets for Devices Used to Treat CHF in the Major
  • World Healthcare Markets by Device Segment
  • Figure 5-3: Trending in the Estimated Markets for Devices to Treat CHF in the
  • Major World Healthcare Markets by Device Segment
  • Figure 5-4: Distribution of the Estimated Markets for Devices to Treat CHF in the Major World Healthcare Markets by Device Segment
  • Table 5-3: The Estimated Markets for Devices Used to Treat CHF in the
  • United States Healthcare Market by Device Segment (Pacemakers, ICDs,
  • LVADs, and TAHs)  
  • Figure 5-5: Trending in the Estimated Markets for Devices Used to Treat CHF in the United States Healthcare Market by Device Segment
  • Figure 5-6: Distribution of the Estimated Markets for Devices Used to Treat
  • CHF in the United States Healthcare Market by Device Segment
  • Table 5-4: The Estimated Markets for Devices Used to Treat CHF in the
  • Five Major European Healthcare Markets by Device Segment
  • Figure 5-7: Trending the Estimated Markets for Devices Used to Treat  CHF in the Five Major European Healthcare Markets by  Device Segment
  • Figure 5-8: Distribution of the Estimated Markets for Devices Used to Treat CHF in the Five Major European Healthcare Markets by Device Segment
  • Table 5-5: The Estimated Markets for Devices Used to Treat CHF in the Japanese
  • Healthcare Market by Device Segment
  • Figure 5-9: Trending in the Estimated Markets for Devices Used to Treat
  • CHF in the Japanese Healthcare Market by Device Segment
  • Figure 5-10: Distribution of the Estimated Markets for Devices Used to Treat CHF in the Japanese Healthcare Market by Device Segment

 

    Global Market for Medical Devices, 14th Edition
    October 31, 2024
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    The Global Market for Medical Devices, 13th Edition
    October 25, 2023
    The Market for Medical Devices, 12th Edition
    November 9, 2022

Related products

  • Placeholder image

    Wound Care Markets: Volume I: Skin Ulcers

    $1,875.00 – $3,750.00
  • Placeholder image

    Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential

    $3,500.00 – $7,000.00
  • Placeholder image

    Wound Care Markets Volume II: Burns

    $1,875.00 – $3,750.00
  • Placeholder image

    Neurological Catheters: A Market Briefing

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Gene Expression Profiling MarketsThe Worldwide Market for Cancer Diagnostics, 3rd Edition
Scroll to top